NeoLight Acquires interVIEW Medical Systems' ROP Certification Program

NeoLight Acquires Phoenix Technology Group

November 17, 2021

Medical Devices

NeoLight LLC, an Arizona State University spinout and Scottsdale-based newborn medical device company, has acquired Phoenix Technology Group LLC (PTG), a provider of ophthalmic imaging devices and a telemedicine platform for retinopathy of prematurity (ROP) screening. The deal expands NeoLight’s product portfolio to include the Phoenix ICON camera systems and the Phoenix CONNECT telemedicine platform and aims to leverage PTG’s global distribution to accelerate adoption of NeoLight’s Skylife neonatal phototherapy products.

Verge Medical Acquires RoVo System from 2MG Medical

June 30, 2025

Medical Devices

Verge Medical, a privately held medical technology company based in Campbell, California, acquired the RoVo System and its patented Temporary Occlusion Embolectomy (TOE) technology from 2MG Medical. The asset purchase (with FDA-cleared technology) expands Verge's portfolio of targeted vascular devices to address distal embolization risk during peripheral and coronary interventions.

Blueprint Education (New Harbor Capital Portfolio) Acquires Rosh Review

November 11, 2021

Education

Blueprint Education, a portfolio company of New Harbor Capital, has acquired Rosh Review, a provider of online medical exam preparation and continuing medical education. The add-on expands Blueprint's medical education offerings and capabilities across the learner journey, integrating Rosh's subscription-based assessment, analytics and institution-facing dashboards that serve 250,000 learners at 740 institutions.

Topcon Healthcare Acquires Intelligent Retinal Imaging Systems (IRIS)

July 30, 2025

Medical Devices

Topcon Healthcare, the digital health and ocular data business of Topcon Corporation, has acquired Intelligent Retinal Imaging Systems (IRIS), a U.S.-based provider of cloud-based, AI-assisted retinal screening technology. The acquisition integrates IRIS into Topcon’s Harmony connected-care platform to expand retinal screening into primary care, strengthen PCP–ECP coordination, and accelerate early disease detection at scale.

LumiThera Acquires Diopsys

November 11, 2021

Medical Devices

LumiThera, a commercial-stage ophthalmic medical device company, entered a definitive merger agreement to acquire Diopsys in a stock-for-stock transaction under which Diopsys will become a wholly owned subsidiary of LumiThera. The deal combines Diopsys' visual electrophysiology diagnostic systems with LumiThera's photobiomodulation treatment platform to create a coordinated light-based theranostic approach for diagnosing, treating and monitoring ocular disease.

MRO Acquires Clinetic

November 18, 2025

Healthcare Services

MRO has acquired Clinetic, an AI-driven patient recruitment management platform that integrates with provider EHRs to identify and enroll patients for clinical trials. MRO plans to incorporate Clinetic’s software across its clinical data platform (including the Q-Centrix Research Network) to expand recruitment capacity, streamline enrollment, and enhance research capabilities for hospitals, health systems, and life sciences sponsors.